Implantation Of Vaginal Construct For Patients With Vaginal Aplasia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Implantation Of Vaginal Construct For Patients With Vaginal Aplasia — Stella

Home/Congenital Mullerian Duct Anomaly/

View on ClinicalTrials.gov

Recruiting

Back to Congenital Mullerian Duct Anomaly trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Key details

Phase

Early testing

Sponsor

Wake Forest University Health Sciences

Enrollment target

~10 participants

Started

June 2023

Primary completion

December 2029

Age range

15 Years – 45 Years

Sex

Female only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.